Artificial antigen-presenting cells for use in adoptive immunotherapy.
about
Nanoengineering approaches to the design of artificial antigen-presenting cellsChimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challengesHuman cell-based artificial antigen-presenting cells for cancer immunotherapy.Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.Therapeutic cancer vaccines: are we there yet?Direct Toll-Like Receptor 8 signaling increases the functional avidity of human CD8+ T lymphocytes generated for adoptive T cell therapy strategies.Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies.Connecting the dots: artificial antigen presenting cell-mediated modulation of natural killer T cells.Expansion of quiescent lung adenocarcinoma CD8+ T cells by MUC1-8-mer peptide-T2 cell-β2 microglobulin complexesIdentification and characterization of an agonistic aptamer against the T cell costimulatory receptor, OX40.Biomimetic delivery with micro- and nanoparticlesArtificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes.Synthesis of nanostructured and biofunctionalized water-in-oil droplets as tools for homing T cellsMagnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activity.Design Advances in Particulate Systems for Biomedical Applications.Management of patients with non-Hodgkin's lymphoma: focus on adoptive T-cell therapy.Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles.RAFTsomes containing epitope-MHC-II complexes mediated CD4+ T cell activation and antigen-specific immune responses.Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs.Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1.Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide-MHC Complexes for T-Cell Receptor Immunotherapy.Surface-Engineering of Red Blood Cells as Artificial Antigen Presenting Cells Promising for Cancer Immunotherapy.Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells.Artificial Antigen Presenting Cells: An Off the Shelf Approach for Generation of Desirable T-Cell Populations for Broad Application of Adoptive Immunotherapy.Photochemical Treatment of APCs Can Eliminate Associated Viruses and Maintain the APC Function for Generating Antigen-Specific CTLs Ex VivoIntegrating Immunology and Microfluidics for Single Immune Cell Analysis
P2860
Q27023634-1B4DEFD2-3092-4684-89C4-E2AA5A3B9ACCQ27025300-9ED31B33-0518-4B3E-81A1-E69ADFB5318EQ34391263-241C876F-CEDA-4570-B45D-645A081DD64EQ34428078-6F1D99CD-43D0-4780-8C0A-1A0575C2FE71Q34786691-FA3513A9-8119-49E6-BAF5-EDFBAC4C4ECBQ35285757-DFF5E928-C3FC-4A0F-8C4D-AE0A373675F6Q35988657-A9B0BD1C-E8C5-481C-999A-E0772D9CE58EQ36383130-B771014D-18D5-4C14-8617-35D1174A9BFEQ36425747-135E08E1-B1C6-454F-9F65-BE67A261ECFBQ36603032-729F11D1-E2FF-47A8-A1F3-6563590A4082Q36768786-D3A9DA05-5A09-4C73-8FDB-9FB9203CEBA5Q37109545-A486A894-BB79-4811-ACBA-4FED426BDF14Q37250284-3F297DB0-1361-4ADE-BBBB-FCD4DC22ABA0Q37731672-CD58C3F9-CF27-4791-9066-EC62442C8DE9Q38873026-C99246B6-2B10-46D2-A19E-7DCD83B03BD1Q38912282-4E7A0CEA-0A6A-4E3C-BB24-EB69526D1926Q39161562-D1C1B8BA-D3A2-41B8-BCB0-DC12358D3EA0Q39300036-66FD5EE0-5538-4ED2-9ED4-B072DDC77E60Q40044791-0A74C9D1-E427-4DF9-B9D8-C8ED55BDDA43Q41338135-6D686530-C7E4-4B7C-8BC8-E70413173580Q45872498-F2EDAF8A-1DC1-479A-BD38-C27E109525B5Q47730058-B75F6B07-CEC6-476E-8649-7B595674D510Q48243270-33FF57E3-9CFC-4E82-8EA7-986B9A678099Q55315844-22AF86A7-2DDA-4E11-8938-E6DF5A13F312Q57492837-C8F90BB5-3C6D-4C6E-BE81-B369E760EF70Q59136363-BFCB5833-F9AA-48D2-98B7-88DB2F09672A
P2860
Artificial antigen-presenting cells for use in adoptive immunotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Artificial antigen-presenting cells for use in adoptive immunotherapy.
@en
Artificial antigen-presenting cells for use in adoptive immunotherapy.
@nl
type
label
Artificial antigen-presenting cells for use in adoptive immunotherapy.
@en
Artificial antigen-presenting cells for use in adoptive immunotherapy.
@nl
prefLabel
Artificial antigen-presenting cells for use in adoptive immunotherapy.
@en
Artificial antigen-presenting cells for use in adoptive immunotherapy.
@nl
P2860
P1433
P1476
Artificial antigen-presenting cells for use in adoptive immunotherapy.
@en
P2093
Cameron J Turtle
Stanley R Riddell
P2860
P304
P356
10.1097/PPO.0B013E3181EB33A6
P577
2010-07-01T00:00:00Z